CN108451779A - A kind of anti-inflammatory essence microcapsules and preparation method thereof - Google Patents
A kind of anti-inflammatory essence microcapsules and preparation method thereof Download PDFInfo
- Publication number
- CN108451779A CN108451779A CN201810530365.3A CN201810530365A CN108451779A CN 108451779 A CN108451779 A CN 108451779A CN 201810530365 A CN201810530365 A CN 201810530365A CN 108451779 A CN108451779 A CN 108451779A
- Authority
- CN
- China
- Prior art keywords
- parts
- microcapsules
- capsule
- inflammatory
- inflammatory essence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/11—Encapsulated compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
- A61K8/988—Honey; Royal jelly, Propolis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Chemical & Material Sciences (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses a kind of anti-inflammatory essence microcapsules and preparation method thereof, microcapsules are the transparent sphere soft capsule of nucleocapsid, wherein cyst wall is sericin shell membrane, and capsule-core is anti-inflammatory essence, and the mass ratio of cyst wall and capsule-core is 1~3:1, a diameter of 2~6mm of microcapsules；By weight, the anti-inflammatory essence includes：15~38 parts of inonotus obliquus extractive from fermentative, 12~28 parts of Rhizoma Atractylodis Macrocephalae extract, 12~21 parts of extract of mulberry twig, 8~19 parts of Ramulus et Folium Mussaendae Pubescentis extract, 3~13 parts of propolis, 1~8 part of jojoba oil, 2~5 parts of glycerine, 1~7 part of Sodium Hyaluronate.(1) anti-inflammatory essence microcapsules of the present invention are using inonotus obliquus extractive from fermentative as main component, while compatibility several functions composition, synergistic effect；(2) anti-inflammatory essence microcapsules of the present invention have the effect of that wrinkle improves, is anti-oxidant, anti-inflammatory.
Description
Technical field
The invention belongs to cosmetic technical fields, are related to a kind of basic facial treatment repair, specially a kind of anti-inflammatory essence
Microcapsules and preparation method thereof.
Background technology
For inonotus obliquus as the medical mushroom for parasitizing birch, scientific name is Inonotus obliquus.As Siberia and North America, Northern Europe etc.
The mushroom for parasitizing birch in 45 degree of north latitude or more area, the effect of being treated to adult diseases such as cancers, is remarkable, by means of virus
Parasitism absorbs myron and grows, and about grows up for 15~20 years.In Russia, from or so 16th century initially as treatment not
The panacea for the disease controlled and spread so far, nineteen fifty-one, Ke Maluofu Science Institutes of Soviet science institute formally begin one's study, at present quilt
Russia regards as formal treatment of cancer medicinal material.
Therefore, various researchs are carried out to inonotus obliquus, it includes inonotus obliquus and Phellinus to disclose in the prior art a kind of
The prostate hyperplasia of extract improves, acne improve, hair promotes purposes composition.It is not right but in existing document
Cosmetic composition in relation to anti-inflammatory, anti-oxidant, whitening, wrinkle improvement etc. is recorded, and so far, utilizes the anti-of inonotus obliquus
Scorching, anti-oxidant, whitening, effect improving wrinkles are still unknown by the people.
Invention content
Present invention solves the technical problem that：For overcome the deficiencies in the prior art, a kind of inonotus obliquus extractive from fermentative is obtained
With the essence of various plants active ingredient compatibility, the present invention provides a kind of anti-inflammatory essence microcapsules and preparation method thereof.
Technical solution：A kind of anti-inflammatory essence microcapsules, microcapsules are the transparent sphere soft capsule of nucleocapsid, wherein
Cyst wall is sericin shell membrane, and capsule-core is anti-inflammatory essence, and the mass ratio of cyst wall and capsule-core is 1~3:1, microcapsules it is a diameter of
2~6mm；By weight, the anti-inflammatory essence includes：15~38 parts of inonotus obliquus extractive from fermentative, Rhizoma Atractylodis Macrocephalae extract 12~
28 parts, 12~21 parts of extract of mulberry twig, 8~19 parts of Ramulus et Folium Mussaendae Pubescentis extract, 3~13 parts of propolis, 1~8 part of jojoba oil, glycerine 2~5
Part, 1~7 part of Sodium Hyaluronate.
Preferably, microcapsules are the transparent sphere soft capsule of nucleocapsid, wherein cyst wall is sericin shell membrane, capsule-core
For anti-inflammatory essence, the mass ratio of cyst wall and capsule-core is 1:1, a diameter of 2mm of microcapsules；By weight, the anti-inflammatory essence
Hua Su includes：15 parts of inonotus obliquus extractive from fermentative, 12 parts of Rhizoma Atractylodis Macrocephalae extract, 12 parts of extract of mulberry twig, 8 parts of Ramulus et Folium Mussaendae Pubescentis extract, bee
3 parts of glue, 1 part of jojoba oil, 2 parts of glycerine, 1 part of Sodium Hyaluronate.
Preferably, microcapsules are the transparent sphere soft capsule of nucleocapsid, wherein cyst wall is sericin shell membrane, capsule-core
For anti-inflammatory essence, the mass ratio of cyst wall and capsule-core is 2:1, a diameter of 4mm of microcapsules；By weight, the anti-inflammatory essence
Hua Su includes：26 parts of inonotus obliquus extractive from fermentative, 21 parts of Rhizoma Atractylodis Macrocephalae extract, 18 parts of extract of mulberry twig, 14 parts of Ramulus et Folium Mussaendae Pubescentis extract, bee
8 parts of glue, 5 parts of jojoba oil, 3 parts of glycerine, 5 parts of Sodium Hyaluronate.
Preferably, microcapsules are the transparent sphere soft capsule of nucleocapsid, wherein cyst wall is sericin shell membrane, capsule-core
For anti-inflammatory essence, the mass ratio of cyst wall and capsule-core is 3:1, a diameter of 6mm of microcapsules；By weight, the anti-inflammatory essence
Hua Su includes：38 parts of inonotus obliquus extractive from fermentative, 28 parts of Rhizoma Atractylodis Macrocephalae extract, 21 parts of extract of mulberry twig, 19 parts of Ramulus et Folium Mussaendae Pubescentis extract, bee
13 parts of glue, 8 parts of jojoba oil, 5 parts of glycerine, 7 parts of Sodium Hyaluronate.
The preparation method of the anti-inflammatory essence microcapsules of any description above, the described method comprises the following steps：
(1) the sericin solution for preparing the metal ion Han 230~270mmol/L adjusts pH to 6~8, after lasting stirring
It is placed in 28~37 DEG C of insulating box and reacts；
(2) solution after reacting step (1) centrifuges precipitation, be washed with deionized remove extra metal from
Then each component of capsule-core is added in son, lasting stirring, which is placed in 28~37 DEG C of insulating box, reacts 5~12 hours；
(3) product after deionized water washing step (2) reaction is used, is placed in vacuum drying chamber dry, you can be made.
Preferably, the mass percent concentration of sericin solution is 3~8%.
Preferably, the metal ion is any one in calcium ion, magnesium ion, divalent manganesetion, zinc ion.
Preferably, the molecular weight of the sericin is 10000~80000Da.
Advantageous effect：(1) anti-inflammatory essence microcapsules of the present invention are using inonotus obliquus extractive from fermentative as main component, together
Shi Peiwu several functions compositions, synergistic effect；(2) anti-inflammatory essence microcapsules of the present invention have wrinkle improvement, antioxygen
Change, anti-inflammatory effect.
Specific implementation mode
Embodiment 1
A kind of anti-inflammatory essence microcapsules, microcapsules are the transparent sphere soft capsule of nucleocapsid, wherein cyst wall is silk gum
Albumen shell membrane, capsule-core are anti-inflammatory essence, and the mass ratio of cyst wall and capsule-core is 1:1, a diameter of 2mm of microcapsules；By weight
Meter, the anti-inflammatory essence include：15 parts of inonotus obliquus extractive from fermentative, 12 parts of Rhizoma Atractylodis Macrocephalae extract, 12 parts of extract of mulberry twig, white tea
8 parts of extract, 3 parts of propolis, 1 part of jojoba oil, 2 parts of glycerine, 1 part of Sodium Hyaluronate.
The preparation method of the anti-inflammatory essence microcapsules, the described method comprises the following steps：
(1) the sericin solution for preparing the metal ion containing 230mmol/L, adjusts pH to 6, and lasting stirring is placed on 28 DEG C
Insulating box in react；
(2) solution after reacting step (1) centrifuges precipitation, be washed with deionized remove extra metal from
Then each component of capsule-core is added in son, lasting stirring, which is placed in 28 DEG C of insulating box, reacts 5 hours；
(3) product after deionized water washing step (2) reaction is used, is placed in vacuum drying chamber dry, you can be made.
The mass percent concentration of sericin solution is 3%.
The metal ion is any one in calcium ion, magnesium ion, divalent manganesetion, zinc ion.
The molecular weight of the sericin is 10000~80000Da.
Embodiment 2
A kind of anti-inflammatory essence microcapsules, microcapsules are the transparent sphere soft capsule of nucleocapsid, wherein cyst wall is silk gum
Albumen shell membrane, capsule-core are anti-inflammatory essence, and the mass ratio of cyst wall and capsule-core is 2:1, a diameter of 4mm of microcapsules；By weight
Meter, the anti-inflammatory essence include：26 parts of inonotus obliquus extractive from fermentative, 21 parts of Rhizoma Atractylodis Macrocephalae extract, 18 parts of extract of mulberry twig, white tea
14 parts of extract, 8 parts of propolis, 5 parts of jojoba oil, 3 parts of glycerine, 5 parts of Sodium Hyaluronate.
The preparation method of the anti-inflammatory essence microcapsules, the described method comprises the following steps：
(1) the sericin solution for preparing the metal ion containing 250mmol/L, adjusts pH to 7, and lasting stirring is placed on 33 DEG C
Insulating box in react；
(2) solution after reacting step (1) centrifuges precipitation, be washed with deionized remove extra metal from
Then each component of capsule-core is added in son, lasting stirring, which is placed in 34 DEG C of insulating box, reacts 7 hours；
(3) product after deionized water washing step (2) reaction is used, is placed in vacuum drying chamber dry, you can be made.
The mass percent concentration of sericin solution is 6%.
The metal ion is any one in calcium ion, magnesium ion, divalent manganesetion, zinc ion.
The molecular weight of the sericin is 10000~80000Da.
Embodiment 3
A kind of anti-inflammatory essence microcapsules, microcapsules are the transparent sphere soft capsule of nucleocapsid, wherein cyst wall is silk gum
Albumen shell membrane, capsule-core are anti-inflammatory essence, and the mass ratio of cyst wall and capsule-core is 3:1, a diameter of 6mm of microcapsules；By weight
Meter, the anti-inflammatory essence include：38 parts of inonotus obliquus extractive from fermentative, 28 parts of Rhizoma Atractylodis Macrocephalae extract, 21 parts of extract of mulberry twig, white tea
19 parts of extract, 13 parts of propolis, 8 parts of jojoba oil, 5 parts of glycerine, 7 parts of Sodium Hyaluronate.
The preparation method of the anti-inflammatory essence microcapsules of any description above, the described method comprises the following steps：
(1) the sericin solution for preparing the metal ion containing 270mmol/L, adjusts pH to 8, and lasting stirring is placed on 37 DEG C
Insulating box in react；
(2) solution after reacting step (1) centrifuges precipitation, be washed with deionized remove extra metal from
Then each component of capsule-core is added in son, lasting stirring, which is placed in 37 DEG C of insulating box, reacts 12 hours；
(3) product after deionized water washing step (2) reaction is used, is placed in vacuum drying chamber dry, you can be made.
The mass percent concentration of sericin solution is 8%.
The metal ion is any one in calcium ion, magnesium ion, divalent manganesetion, zinc ion.
The molecular weight of the sericin is 10000~80000Da.
The anti-inflammatory essence microcapsules that Examples 1 to 3 prepares are detected, the results are shown in table below：
Claims (8)
1. a kind of anti-inflammatory essence microcapsules, which is characterized in that microcapsules are the transparent sphere soft capsule of nucleocapsid, wherein
Cyst wall is sericin shell membrane, and capsule-core is anti-inflammatory essence, and the mass ratio of cyst wall and capsule-core is 1~3:1, microcapsules it is a diameter of
2~6mm；By weight, the anti-inflammatory essence includes：15~38 parts of inonotus obliquus extractive from fermentative, Rhizoma Atractylodis Macrocephalae extract 12~
28 parts, 12~21 parts of extract of mulberry twig, 8~19 parts of Ramulus et Folium Mussaendae Pubescentis extract, 3~13 parts of propolis, 1~8 part of jojoba oil, glycerine 2~5
Part, 1~7 part of Sodium Hyaluronate.
2. a kind of anti-inflammatory essence microcapsules according to claim 1, which is characterized in that microcapsules are the saturating of nucleocapsid
Bright spherical shape soft capsule, wherein cyst wall is sericin shell membrane, and capsule-core is anti-inflammatory essence, and the mass ratio of cyst wall and capsule-core is 1:
1, a diameter of 2mm of microcapsules；By weight, the anti-inflammatory essence includes：15 parts of inonotus obliquus extractive from fermentative, Rhizoma Atractylodis Macrocephalae carry
Take 12 parts of object, 12 parts of extract of mulberry twig, 8 parts of Ramulus et Folium Mussaendae Pubescentis extract, 3 parts of propolis, 1 part of jojoba oil, 2 parts of glycerine, Sodium Hyaluronate 1
Part.
3. a kind of anti-inflammatory essence microcapsules according to claim 1, which is characterized in that microcapsules are the saturating of nucleocapsid
Bright spherical shape soft capsule, wherein cyst wall is sericin shell membrane, and capsule-core is anti-inflammatory essence, and the mass ratio of cyst wall and capsule-core is 2:
1, a diameter of 4mm of microcapsules；By weight, the anti-inflammatory essence includes：26 parts of inonotus obliquus extractive from fermentative, Rhizoma Atractylodis Macrocephalae carry
Take 21 parts of object, 18 parts of extract of mulberry twig, 14 parts of Ramulus et Folium Mussaendae Pubescentis extract, 8 parts of propolis, 5 parts of jojoba oil, 3 parts of glycerine, Sodium Hyaluronate
5 parts.
4. a kind of anti-inflammatory essence microcapsules according to claim 1, which is characterized in that microcapsules are the saturating of nucleocapsid
Bright spherical shape soft capsule, wherein cyst wall is sericin shell membrane, and capsule-core is anti-inflammatory essence, and the mass ratio of cyst wall and capsule-core is 3:
1, a diameter of 6mm of microcapsules；By weight, the anti-inflammatory essence includes：38 parts of inonotus obliquus extractive from fermentative, Rhizoma Atractylodis Macrocephalae carry
Take 28 parts of object, 21 parts of extract of mulberry twig, 19 parts of Ramulus et Folium Mussaendae Pubescentis extract, 13 parts of propolis, 8 parts of jojoba oil, 5 parts of glycerine, hyaluronic acid
7 parts of sodium.
5. the preparation method of any anti-inflammatory essence microcapsules of Claims 1 to 4, which is characterized in that the method includes
Following steps：
(1) the sericin solution for preparing the metal ion Han 230~270mmol/L, adjusts pH to 6~8, and lasting stirring is placed on
It is reacted in 28~37 DEG C of insulating box；
(2) solution after reacting step (1) centrifuges precipitation, is washed with deionized and removes extra metal ion, so
The each component of capsule-core is added afterwards, lasting stirring, which is placed in 28~37 DEG C of insulating box, reacts 5~12 hours；
(3) product after deionized water washing step (2) reaction is used, is placed in vacuum drying chamber dry, you can be made.
6. the preparation method of anti-inflammatory essence microcapsules according to claim 5, which is characterized in that sericin solution
Mass percent concentration is 3~8%.
7. the preparation method of anti-inflammatory essence microcapsules according to claim 5, which is characterized in that the metal ion is
Any one in calcium ion, magnesium ion, divalent manganesetion, zinc ion.
8. the preparation method of anti-inflammatory essence microcapsules according to claim 5, which is characterized in that the sericin
Molecular weight is 10000~80000Da.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810530365.3A CN108451779A (en) | 2018-05-29 | 2018-05-29 | A kind of anti-inflammatory essence microcapsules and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810530365.3A CN108451779A (en) | 2018-05-29 | 2018-05-29 | A kind of anti-inflammatory essence microcapsules and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108451779A true CN108451779A (en) | 2018-08-28 |
Family
ID=63215693
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810530365.3A Withdrawn CN108451779A (en) | 2018-05-29 | 2018-05-29 | A kind of anti-inflammatory essence microcapsules and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108451779A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112194715A (en) * | 2020-11-03 | 2021-01-08 | 西南大学 | Anti-inflammatory sericin peptide and application thereof |
| CN112225791A (en) * | 2020-11-03 | 2021-01-15 | 西南大学 | Sericin peptide and application thereof |
| CN112300258A (en) * | 2020-11-03 | 2021-02-02 | 西南大学 | Anti-inflammatory sericin peptide and application thereof |
-
2018
- 2018-05-29 CN CN201810530365.3A patent/CN108451779A/en not_active Withdrawn
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112194715A (en) * | 2020-11-03 | 2021-01-08 | 西南大学 | Anti-inflammatory sericin peptide and application thereof |
| CN112225791A (en) * | 2020-11-03 | 2021-01-15 | 西南大学 | Sericin peptide and application thereof |
| CN112300258A (en) * | 2020-11-03 | 2021-02-02 | 西南大学 | Anti-inflammatory sericin peptide and application thereof |
| CN112225791B (en) * | 2020-11-03 | 2021-10-22 | 西南大学 | Sericin peptide and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108778242B (en) | Cosmetic use of ingredients derived from marrubium vulgare | |
| CN108451779A (en) | A kind of anti-inflammatory essence microcapsules and preparation method thereof | |
| JPH03151315A (en) | Aqueous aloe solution and production thereof | |
| CN104940064A (en) | Brasenia schreberi emulsion | |
| CN105769725A (en) | Rosemary moisturizing water and making method thereof | |
| CN104739746A (en) | Pure natural nano plant facial mask | |
| CN109381407A (en) | One kind is releived anti-ageing Aloe Vera Gel of moisturizing and preparation method thereof | |
| CN110237003A (en) | A kind of perfume Flos Nelumbinis extract and its application in skin care item | |
| CN105254716B (en) | A kind of anti-oxidant hexapeptide of leek seed and the preparation method and application thereof | |
| CN107789316A (en) | A kind of moisturizing antioxidant composition of extract of stem cell containing pot marigold and its application | |
| CN106349038B (en) | A method of preparing muskone | |
| CN109172452B (en) | Compound extract of white paeony root and sophora flower and application of compound extract as cosmetic additive | |
| CN103705431A (en) | Fish source collagen antioxidant peptide beauty mask and preparation method thereof | |
| CN104958205A (en) | Water shield essential lotion | |
| CN104958203B (en) | Water shield facial mask liquid | |
| CN109172500A (en) | Nanometer plants extraction facial mask | |
| KR101851742B1 (en) | Cosmetic composition containing porifera spicule coated with sawhangsan and method for manufacturing the same | |
| CN109303734A (en) | A kind of perfume Flos Nelumbinis extract and its preparing the application in cosmetics | |
| CN108309887A (en) | A kind of plant mask and its preparation process | |
| CN107397712A (en) | A kind of snake gall facial mask and preparation method thereof | |
| CN105662998B (en) | A kind of Yak-skin Gelatin original facial mask and preparation method with protectiving ultraviolet | |
| CN107823008A (en) | A kind of essence additive extracted from natural plants and preparation method thereof | |
| CN107375154A (en) | A kind of nti-freckle white composition and preparation method thereof only | |
| CN109091440B (en) | Preparation method of compound plant extract and application of compound plant extract as SOD cosmetic additive | |
| KR101382203B1 (en) | Method for production of preventing hair loss and brain waves stabilization composion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20180828 |
|
| WW01 | Invention patent application withdrawn after publication |